Here are all of the changes coming to the S&P 500
- Stocks being added in: Palantir $PLTR (+0.62%), $DELL (+0.83%) and $ERIE
- Stocks being removed: American Airlines $AAL (+1.11%), $ETSY (+0.28%), Bio-Rad $BIO (+1.26%)
Bio RadUS0905722072BIOBIO
Bio Rad
US0905722072
BIO
BIO
Financials
Market Cap
$9.42B5Y beta
0.95EPS (TTM)
-$47.03Free Float
19.33MRevenue (TTM)
$2.56BEBITDA (TTM)
$489.77MFree Cashflow (TTM)
$177.42MPricing
1D span
$340.78$346.41
52W span
$261.59$366.30
Analyst Ratings
The price target is $352.80 and the stock is covered by 5 analysts.
Buy
1
Hold
4
Sell
0
Information
8030Scientific & Technical Instr.Health Care
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Identifier
ISIN
US0905722072
Primary Ticker
BIO